RT Journal Article
SR Electronic
T1 Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.13.21267698
DO 10.1101/2021.12.13.21267698
A1 Shibata, Yoko
A1 Minemura, Hiroyuki
A1 Suzuki, Yasuhito
A1 Nikaido, Takefumi
A1 Tanino, Yoshinori
A1 Fukuhara, Atsuro
A1 Kanno, Ryuzo
A1 Saito, Hiroyuki
A1 Suzuki, Shuzo
A1 Ishii, Taeko
A1 Inokoshi, Yayoi
A1 Sando, Eiichiro
A1 Sakuma, Hirofumi
A1 Kobayashi, Tatsuho
A1 Kume, Hiroaki
A1 Kamimoto, Masahiro
A1 Aoki, Hideko
A1 Takama, Akira
A1 Kamiyama, Takamichi
A1 Nakayama, Masaru
A1 Saito, Kiyoshi
A1 Tanigawa, Koichi
A1 Sato, Masahiko
A1 Kanbe, Toshiyuki
A1 Kanzaki, Norio
A1 Azuma, Teruhisa
A1 Sakamoto, Keiji
A1 Nakamura, Yuichi
A1 Otani, Hiroshi
A1 Waragai, Mitsuru
A1 Maeda, Shinsaku
A1 Ishida, Tokiya
A1 Sugino, Keishi
A1 Inage, Minoru
A1 Hirama, Noriyuki
A1 Furuyama, Kodai
A1 Fukushima, Shigeyuki
A1 Saito, Hiroshi
A1 Machiya, Jun-ichi
A1 Machida, Hiroyoshi
A1 Abe, Koya
A1 Iwabuchi, Katsuyoshi
A1 Katagiri, Yuji
A1 Aida, Yasuko
A1 Abe, Yuki
A1 Ota, Takahito
A1 Ishizawa, Yuki
A1 Tsukada, Yasuhiko
A1 Yamada, Ryuki
A1 Sato, Riko
A1 Omuna, Takumi
A1 Tomita, Hikaru
A1 Saito, Mikako
A1 Watanabe, Natsumi
A1 Rikimaru, Mami
A1 Kawamata, Takaya
A1 Umeda, Takashi
A1 Morimoto, Julia
A1 Togawa, Ryuichi
A1 Sato, Yuki
A1 Saito, Junpei
A1 Kanazawa, Kenya
A1 Omae, Kenji
A1 Noriaki, Kurita
A1 Iseki, Ken
YR 2021
UL http://medrxiv.org/content/early/2021/12/14/2021.12.13.21267698.abstract
AB BACKGROUND Due to the dissemination of vaccination against severe acute respiratory syndrome coronavirus 2 in the elderly, the virus-susceptible subjects have shifted to unvaccinated non-elderlies. The risk factors of COVID-19 deterioration in non-elderly patients without respiratory failure have not yet been determined. This study was aimed to create simple predicting method to identify such patients who have high risk for exacerbation.METHODS We analyzed the data of 1,675 patients aged under 65 years who were admitted to hospitals with mild-to-moderate COVID-19. For validation, 324 similar patients were enrolled. Disease progression was defined as administration of medication, oxygen inhalation and mechanical ventilator starting one day or longer after admission.RESULTS The patients who exacerbated tended to be older, male, had histories of smoking, and had high body temperatures, lower oxygen saturation, and comorbidities such as diabetes/obesity and hypertension. Stepwise logistic regression analyses revealed that comorbidities of diabetes/obesity, age ≥ 40 years, body temperature ≥ 38°C, and oxygen saturation < 96% (DOATS) were independent risk factors of worsening COVID-19. As a result two predictive scores were created: DOATS score, which includes all the above risk factors; and DOAT score, which includes all factors except for oxygen saturation. In the original cohort, the areas under the receiver operating characteristic curve of the DOATS and DOAT scores were 0.789 and 0.771, respectively. In the validation, the areas were 0.702 and 0.722, respectively.CONCLUSION We established two simple prediction scores that can quickly evaluate the risk of progression of COVID-19 in non-elderly, mild/moderate patients.Summary The risk stratification models using independent risks, namely comorbidity of diabetes or obesity, age ≥ 40 years, high body temperature ≥ 38□, and oxygen saturation < 96%, DOATS and DOAT scores, predicted worsening COVID-19 in patients with mild-to-moderate cases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Fukushima Medical University gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.AbbreviationsCOVID-19coronavirus disease 2019DOATcomorbidity of diabetes/obesity, age ≥ 40 years, and body temperature ≥ 38°CDOATScomorbidity of diabetes/obesity, age ≥ 40 years, body temperature ≥ 38°C, and oxygen saturation < 96%ECMOextracorporeal membrane oxygenationSARS-CoV-2severe acute respiratory syndrome coronavirus 2